M&A Deal Summary |
|
---|---|
Date | 2020-09-15 |
Target | Fiagon AG |
Sector | Medical Products |
Buyer(s) | Intersect ENT |
Deal Type | Add-on Acquisition |
Deal Value | 60M USD |
Advisor(s) | Oppenheimer & Co. (Financial) Morrison & Foerster (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2003 |
Sector | Medical Products |
Employees | 406 |
Revenue | 81M USD (2020) |
Intersect ENT is a medical technology company dedicated to advancing the treatment of ear, nose, and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients. Intersect ENT was founded in 2003 and is headquartered in Menlo Park, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
Country (Germany) | 1 of 1 |
Year (2020) | 1 of 1 |
Size (of disclosed) | 1 of 1 |